SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 --------------- FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 2, 1999 BIOJECT MEDICAL TECHNOLOGIES INC. (Exact Name of Registrant as Specified in Charter) Oregon (State or Other Jurisdiction of Incorporation) 0-15360 93-1099680 (Commission File Number) (IRS Employer Identification No.) 7620 S.W. Bridgeport Road Portland, Oregon 97224 (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code (503) 639-7221 (Former Name or Former Address, if Changed Since Last Report) Page 1 of 5 Pages Exhibit Index on Page 4 Item 2. Acquisition or Disposition of Assets The press release attached as Exhibit 99.1 is incorporated by reference herein. Item 7. Exhibits 99.1 Press release dated July 2, 1999 Page 2 of 5 Pages SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIOJECT MEDICAL TECHNOLOGIES INC. Date: July 12, 1999 By /s/ Michael A. Temple -------------------------------------------- Michael A. Temple Vice President, Chief Financial Officer and Secretary Page 3 of 5 Pages Exhibit Index Exhibit Number Exhibit Page - ------ ------- ---- 99.1 Press release dated July 2, 1999 Page 4 of 5 Pages